Business Combinations - Schedule of Pro Forma Financial Information (Details) - BioMedomics, Inc - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2025 |
|
| Business Combination [Line Items] | ||
| Net revenues | $ 27,303 | $ 88,998 |
| Net income loss | $ (13,838) | $ (49,609) |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|